Michelle Benrath, NP
Nurse Practitioner · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location · One Medical Group Inc · 330 clinicians in this group
Looking this up.
Hospitals listed: Mills-Peninsula Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Michelle Benrath’s office at (408) 228-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$7,814
Medicare paid this office $7,814 for 38 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 21 | $2,903 | $88 |
| Short return visit (20+ min) | 18 | $1,951 | $67 |
| Insertion of needle into vein for collection of blood sample | 15 | $173 | $9 |
Who their Medicare patients are
38 Original Medicare patients in 2024. Average age 72 · Women 53% · Health risk score 0.87. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 50%.
The office billed $62,015, Medicare allowed $10,654 and paid $7,814; for 131 services of 21 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 38 | 131 | 72 | 0.87 | $62,015 | $7,814 |
| 2023 | 35 | 75 | 72 | 1.02 | $33,716 | $4,319 |
| 2022 | 16 | 32 | 75 | 0.62 | $15,640 | $2,253 |
| 2021 | 15 | 21 | 72 | 0.58 | $9,840 | $1,610 |
| 2019 | 16 | 24 | 69 | 1.35 | $9,180 | $984 |
| 2018 | 34 | 54 | 70 | 0.57 | $22,720 | $2,862 |
| 2017 | 33 | 57 | 68 | 0.68 | $20,480 | $3,542 |
| 2015 | 25 | 34 | 60 | 1.62 | $4,750 | $1,509 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Return visit (30+ min) | 11 | $1,251 | $83 |
| Insertion of needle into vein for collection of blood sample | 17 | $168 | $8 |
2019: 1 service
| Short return visit (20+ min) | 13 | $595 | $37 |
2018: 2 services
| Return visit (30+ min) | 12 | $1,089 | $68 |
| Short return visit (20+ min) | 21 | $972 | $37 |
2017: 1 service
| Short return visit (20+ min) | 26 | $2,396 | $58 |
2015: 2 services
| Short return visit (20+ min) | 18 | $840 | $38 |
| Return visit (30+ min) | 11 | $650 | $59 |
Drugs they prescribed that Part D paid
$40,047
Pharmacies billed $40,047 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 7% of their Part D prescriptions (19 of 260) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
226 generic and 34 brand-name prescriptions · $40,047 in drug cost · 14 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rosuvastatin | 18 | $473 | $26 |
| Hydrocodone-Acetaminophen | 15 | $226 | $15 |
| Prednisone | 11 | $61 | $6 |
Year by year
| 2024 | 260 | 43 | 7% (19) | 13% | $40,047 |
| 2023 | 99 | 24 | None | 14% | $11,145 |
| 2022 | 50 | None | 24% (12) | None | $4,285 |
| 2021 | 59 | 13 | 20% (12) | None | $13,971 |
| 2020 | 92 | 26 | 13% (12) | None | $5,014 |
| 2019 | 144 | 32 | 9% (13) | 13% | $6,382 |
| 2018 | 139 | 34 | None | 16% | $4,672 |
| 2017 | 132 | 46 | None | 13% | $7,643 |
| 2016 | 1,229 | 84 | 3% (38) | 39% | $340,499 |
| 2015 | 3,676 | 177 | 3% (109) | 50% | $2,838,158 |
| 2014 | 850 | 79 | 2% (16) | 50% | $683,493 |
| 2013 | 811 | 51 | None | 55% | $325,207 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Hydrocodone-Acetaminophen | 12 | $227 | $19 |
2021: 1 drug
| Hydrocodone-Acetaminophen | 12 | $279 | $23 |
2020: 1 drug
| Hydrocodone-Acetaminophen | 12 | $280 | $23 |
2019: 2 drugs
| Hydrocodone-Acetaminophen | 13 | $377 | $29 |
| Lisinopril | 15 | $155 | $10 |
2018: 1 drug
| Levothyroxine | 11 | $300 | $27 |
2017: 1 drug
| Ibu | 11 | $23 | $2 |
2016: 40 drugs
| Nexium | 50 | $12,496 | $250 |
| Welchol | 15 | $8,075 | $538 |
| Advair Diskus | 17 | $7,467 | $439 |
| Crestor | 24 | $6,804 | $283 |
| Janumet | 17 | $5,205 | $306 |
| Januvia | 11 | $3,939 | $358 |
| Symbicort | 14 | $3,517 | $251 |
| Omega-3 Acid Ethyl Esters | 18 | $3,341 | $186 |
| Ventolin Hfa | 26 | $1,751 | $67 |
| Proair Hfa | 30 | $1,693 | $56 |
| Voltaren | 14 | $1,332 | $95 |
| Endocet | 11 | $1,063 | $97 |
| Oxycodone | 21 | $906 | $43 |
| Valacyclovir | 12 | $509 | $42 |
| Ibandronate | 11 | $443 | $40 |
| Zolpidem | 48 | $314 | $7 |
| Mirtazapine | 12 | $267 | $22 |
| Ammonium Lactate | 13 | $253 | $19 |
| Metoprolol | 14 | $222 | $16 |
| Donepezil | 15 | $218 | $15 |
| Gabapentin | 23 | $218 | $9 |
| Tamsulosin | 12 | $172 | $14 |
| Atorvastatin | 25 | $162 | $6 |
| Montelukast | 16 | $152 | $10 |
| Ranitidine | 23 | $139 | $6 |
| Levothyroxine | 11 | $130 | $12 |
| Fluticasone Propionate | 16 | $124 | $8 |
| Amlodipine Besylate | 49 | $114 | $2 |
| Hydrocortisone | 19 | $91 | $5 |
| Omeprazole | 15 | $86 | $6 |
| Simvastatin | 38 | $63 | $2 |
| Hydrochlorothiazide | 24 | $61 | $3 |
| Lisinopril | 21 | $50 | $2 |
| Gemfibrozil | 11 | $50 | $5 |
| Citalopram Hbr | 19 | $47 | $2 |
| Metoprolol | 27 | $35 | $1 |
| Metformin | 19 | $33 | $2 |
| Glipizide | 13 | $31 | $2 |
| Atenolol | 11 | $22 | $2 |
| Lisinopril-Hydrochlorothiazide | 15 | $17 | $1 |
2015: 84 drugs
| Harvoni | 16 | $506,184 | $31,637 |
| Sovaldi | 15 | $426,657 | $28,444 |
| Triumeq | 82 | $184,850 | $2,254 |
| Complera | 75 | $172,005 | $2,293 |
| Truvada | 119 | $163,530 | $1,374 |
| Stribild | 54 | $136,881 | $2,535 |
| Atripla | 50 | $124,894 | $2,498 |
| Isentress | 94 | $115,217 | $1,226 |
| Tivicay | 76 | $106,356 | $1,399 |
| Prezista | 78 | $100,080 | $1,283 |
| Reyataz | 60 | $77,587 | $1,293 |
| Epzicom | 54 | $64,054 | $1,186 |
| Intelence | 41 | $42,111 | $1,027 |
| Viread | 45 | $41,116 | $914 |
| Prezcobix | 26 | $37,760 | $1,452 |
| Norvir | 126 | $36,305 | $288 |
| Lexiva | 12 | $20,153 | $1,679 |
| Kaletra | 22 | $19,358 | $880 |
| Edurant | 23 | $18,635 | $810 |
| Nexium | 59 | $14,716 | $249 |
| Lantus Solostar | 34 | $13,443 | $395 |
| Crestor | 48 | $10,291 | $214 |
| Abacavir | 21 | $8,457 | $403 |
| Spiriva | 24 | $7,731 | $322 |
| Advair Diskus | 15 | $5,970 | $398 |
| Premarin | 12 | $5,343 | $445 |
| Proair Hfa | 87 | $4,693 | $54 |
| Omega-3 Acid Ethyl Esters | 24 | $4,463 | $186 |
| Flovent Hfa | 18 | $3,569 | $198 |
| Oxycodone | 49 | $2,818 | $58 |
| Symbicort | 11 | $2,777 | $252 |
| Ventolin Hfa | 40 | $1,914 | $48 |
| Endocet | 21 | $1,713 | $82 |
| Valacyclovir | 43 | $1,688 | $39 |
| Voltaren | 18 | $1,224 | $68 |
| Ibandronate | 11 | $1,093 | $99 |
| Testosterone Cypionate | 25 | $821 | $33 |
| Gabapentin | 58 | $746 | $13 |
| Azithromycin | 38 | $743 | $20 |
| Dapsone | 24 | $738 | $31 |
| Ketoconazole | 16 | $710 | $44 |
| Oxycodone-Acetaminophen | 12 | $686 | $57 |
| Montelukast | 45 | $666 | $15 |
| Levothyroxine | 44 | $629 | $14 |
| Pravastatin | 33 | $610 | $18 |
| Bd Ultra-Fine Pen Needle | 15 | $548 | $37 |
| Atorvastatin | 57 | $499 | $9 |
| Ammonium Lactate | 29 | $398 | $14 |
| Tamsulosin | 22 | $394 | $18 |
| Hydrocortisone | 33 | $347 | $11 |
| Lisinopril | 87 | $308 | $4 |
| Metoprolol | 15 | $296 | $20 |
| Ranitidine | 48 | $288 | $6 |
| Clopidogrel | 26 | $283 | $11 |
| Ibuprofen | 45 | $281 | $6 |
| Amlodipine Besylate | 89 | $261 | $3 |
| Sulfamethoxazole-Trimethoprim | 36 | $254 | $7 |
| Fluticasone Propionate | 25 | $247 | $10 |
| Nystatin | 13 | $242 | $19 |
| Zolpidem | 47 | $242 | $5 |
| Omeprazole | 24 | $210 | $9 |
| Metformin | 76 | $202 | $3 |
| Gemfibrozil | 23 | $198 | $9 |
| Acyclovir | 17 | $188 | $11 |
| Loperamide | 21 | $183 | $9 |
| Enalapril Maleate | 14 | $177 | $13 |
| Metoclopramide | 28 | $156 | $6 |
| Meclizine | 12 | $153 | $13 |
| Fluconazole | 12 | $134 | $11 |
| Naproxen | 26 | $129 | $5 |
| Warfarin | 14 | $94 | $7 |
| Glimepiride | 13 | $93 | $7 |
| Losartan | 21 | $83 | $4 |
| Hydrochlorothiazide | 25 | $82 | $3 |
| Prednisone | 18 | $82 | $5 |
| Lisinopril-Hydrochlorothiazide | 25 | $64 | $3 |
| Carvedilol | 13 | $63 | $5 |
| Furosemide | 28 | $59 | $2 |
| Metoprolol | 21 | $56 | $3 |
| Metformin Hcl Er | 12 | $54 | $4 |
| Simvastatin | 16 | $43 | $3 |
| Alcohol Prep Pads | 14 | $38 | $3 |
| Meloxicam | 12 | $34 | $3 |
| Atenolol | 14 | $26 | $2 |
2014: 23 drugs
| Stribild | 24 | $60,261 | $2,511 |
| Prezista | 39 | $46,212 | $1,185 |
| Truvada | 32 | $41,134 | $1,285 |
| Isentress | 25 | $28,739 | $1,150 |
| Complera | 11 | $22,753 | $2,068 |
| Reyataz | 15 | $17,952 | $1,197 |
| Norvir | 56 | $15,226 | $272 |
| Epzicom | 13 | $14,578 | $1,121 |
| Tivicay | 11 | $13,740 | $1,249 |
| Abacavir | 12 | $3,716 | $310 |
| Lamivudine | 12 | $2,569 | $214 |
| Proair Hfa | 24 | $1,182 | $49 |
| Atorvastatin | 14 | $390 | $28 |
| Azithromycin | 14 | $258 | $18 |
| Pravastatin | 12 | $251 | $21 |
| Omeprazole | 21 | $249 | $12 |
| Gabapentin | 18 | $242 | $13 |
| Lisinopril | 36 | $152 | $4 |
| Tamsulosin | 11 | $148 | $13 |
| Sulfamethoxazole-Trimethoprim | 14 | $95 | $7 |
| Ibuprofen | 14 | $72 | $5 |
| Metformin | 14 | $68 | $5 |
| Hydrochlorothiazide | 15 | $46 | $3 |
2013: 19 drugs
| Truvada | 51 | $63,853 | $1,252 |
| Prezista | 55 | $61,309 | $1,115 |
| Atripla | 16 | $31,080 | $1,943 |
| Epzicom | 28 | $29,522 | $1,054 |
| Norvir | 72 | $19,642 | $273 |
| Isentress | 17 | $18,494 | $1,088 |
| Sustiva | 12 | $8,074 | $673 |
| Abacavir | 17 | $6,707 | $395 |
| Nexium | 15 | $3,245 | $216 |
| Lovaza | 17 | $2,748 | $162 |
| Proair Hfa | 14 | $653 | $47 |
| Atorvastatin | 19 | $533 | $28 |
| Fluticasone Propionate | 13 | $361 | $28 |
| Pravastatin | 21 | $342 | $16 |
| Lisinopril-Hydrochlorothiazide | 30 | $265 | $9 |
| Omeprazole | 26 | $250 | $10 |
| Metformin Hcl Er | 19 | $173 | $9 |
| Lisinopril | 26 | $158 | $6 |
| Glipizide Er | 11 | $83 | $8 |
Money from drug and device companies
$19 in 2025
| 2025 | 1 | 1 | None | $19 |
| 2024 | 1 | 1 | None | $17 |
| 2021 | 1 | 1 | None | $36 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Gilead Sciences | None | $19 | 1 payment
|
See the published payment
| Gilead Sciences | Meals · 2025-09-17 | None | $19 |
See earlier years (2024, 2021)
2024: $17
| Lilly USA | Zepbound | $17 | 1 payment
|
2021: $36
| Janssen Biotech | Symtuza | $36 | 1 payment
|
Professional record
- NPI
- 1467730945
- Licence
- CA 95004549, NY 630519-1, NY F305978
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LA2200X (363LA2200X); Federal specialty code 163W00000X (163W00000X)
- Mailing address
- 1 Embarcadero Ctr Ste 1900, San Francisco, CA, 94111
- NPI first listed
- 2011-08-01
- NPI last updated
- 2025-03-17
- NPI record certified
- 2025-03-17
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 501 2nd St Ste 415, San Francisco, CA, 94107